US Stock MarketDetailed Quotes
AZNCF ASTRAZENECA PLC
- 142.433
- 0.0000.00%
15min DelayClose Nov 4 16:00 ET
220.81BMarket Cap34.57P/E (TTM)
0.000High0.000Low0Volume0.000Open142.433Pre Close0.00Turnover0.00%Turnover Ratio37.38P/E (Static)1.55BShares175.00052wk High5.59P/B220.81BFloat Cap115.59852wk Low2.89Dividend TTM1.55BShs Float175.000Historical High2.03%Div YieldTTM0.00%Amplitude99.419Historical Low--Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
ASTRAZENECA PLC Stock Forum
📊⚡️📊
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies (GRCL.US)$ by ...
$Gracell Biotechnologies (GRCL.US)$
$ASTRAZENECA PLC (AZNCF.US)$
$AstraZeneca (AZN.US)$
— Shares rose 1.4% after Jefferies upgraded the stock to buy from hold. The upgrade comes after one of its breast cancer therapies, in joint development with Daiichi Sankyo, came out with positive results in a late-stage trial on Friday.
$Urban Outfitters (URBN.US)$, $Foot Locker (FL.US)$
— Shares of Urban Outfitters fell 4%, while Foot Locker slid 2.9% before the bell after Jefferies downgraded the stocks to hold from...
— Shares of the British pharmaceutical company gained more $Wayfair (W.US)$ than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.
$Wayfair (W.US)$
— Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary.
Chinese e-commer...
Gapping up
$Intel (INTC.US)$
(Shares popped 6.7% after the chipmaker posted better-than-expected second-quarter results and a return to profitability after two consecutive losing periods. Intel’s forecast for the third quarter also came in above analyst expectations. The company reported adjusted earnings of 13 cents a share on revenues of $12.95 billion.)
$Roku Inc (ROKU.US)$
(The streaming stock...
As investors evaluate potential sectors for their next moves in the midst of the 2023 market outlook, healthcare emerges as an attractive option. This post explores three compelling reasons why healthcare warrants consideration: its defensive nature in the face of a looming recession, its historical tendency to perform better in the second half of the year, and the recent corrections in major healthcare tickers, presenting f...
Gapping up
$Rivian Automotive (RIVN.US)$ +6.5% (Rivian popped 6.5% in premarket trading, adding to Monday's gains after the electric vehicle maker reported 12,640 deliveries during the second quarter. The deliveries were up 59% from the previous quarter and beat analyst expectations of 11,000 vehicles, according to StreetAccount.)
$ASTRAZENECA PLC (AZNCF.US)$ +3% (The drugmaker climbed nearly 3%...
No comment yet